Lipid Nanoparticles-Based mRNA Delivery System offers a comprehensive exploration of lipid nanoparticles (LNPs), the most promising delivery vehicles for mRNA. The book consolidates current knowledge, identifies research gaps, and provides insights into the latest developments in LNP technologies, making it an essential resource for researchers, pharmaceutical developers, and clinicians at the forefront of mRNA therapeutics. Exploring the intricacies of LNP formulation, the book covers a wide range of topics, including the fundamental principles of lipid nanoparticles, design strategies for effective mRNA encapsulation, and the unique challenges associated with various routes of administration-such as intravenous, oral, transdermal, and intranasal delivery.
The book also examines the therapeutic applications of lipid-based systems, particularly in vaccines and cancer immunotherapy, while addressing critical challenges like immunogenicity and regulatory considerations. Final sections provide a forward-looking perspective on future trends and innovations in lipid-based mRNA delivery systems, ensuring that readers are well-equipped to navigate this rapidly evolving field.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Part I: Foundations of Lipid Nanoparticle (LNP) Technology1. Introduction to mRNA and RNA Therapeutics
2. Basic Principles of Lipid Nanoparticles (LNPs)
3. Mechanisms of mRNA Delivery via LNPs
Part II: Design and Formulation of Lipid Nanoparticles for mRNA Delivery
4. Lipid Nanoparticle Formulation Strategies
5. Lipid Nanoparticle Characterization
Part III: Administration Routes for Lipid-based mRNA Delivery
6. Intravenous (IV) Administration of mRNA-LNPs
7. Transdermal Administration of mRNA-LNPs
8. Intranasal Administration of mRNA-LNPs
9. Intramuscular Administration of mRNA LNPs
10. Other Emerging Routes of mRNA Delivery
Part IV: Applications of Lipid-based mRNA Delivery Systems
11. mRNA Vaccines: Revolutionizing Preventive Medicine
12. mRNA in Cancer Immunotherapy
Part V: Challenges, Solutions, and Future Directions
13. Immunogenicity and Toxicity of mRNA-LNPs
14. Regulatory Considerations for mRNA-LNP-Based Therapeutics
15. Future Trends in Lipid-based mRNA Delivery
Authors
Raj Kumar University of Petroleum and Energy Studies, Dehradun, India.Dr. Raj Kumar has a strong academic and research background in lipid-based nanocarriers and their applications in drug delivery. His work has focused on designing, synthesizing, and characterizing various nanocarriers for advanced therapeutic solutions, such as lipid, polymeric, mucoadhesive, and stimuli ROS-responsive nanoparticles. This foundational expertise enables him to critically assess the field's emerging trends, challenges, and innovations.
